Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq's stockholders' equity requirement, with the Nasdaq Hearings Panel granting the company's request for continued listing subject to certain conditions.
The Nasdaq compliance milestone removes one specific listing issue for Glucotrack as management continues its strategic transformation, although the company said it is still working toward full compliance with all applicable Nasdaq standards.
Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq's stockholders' equity requirement.
The Nasdaq Hearings Panel granted continued listing subject to certain conditions, meaning compliance remains an area for investors to monitor.
Management views the decision as part of efforts to strengthen Glucotrack's financial foundation and reposition the business for longer-term growth.

#gctk #management #stockholders